


Dr. Olufunmilayo Olopade, MD
Dr. Olufunmilayo Olopade, MD is a medical oncologist in Chicago, IL and has over 40 years of experience in the medical field. She graduated from University of Ibadan School of Medicine in 1980. She is affiliated with The University of Chicago Medical Center.
Practice
5841 S Maryland Ave Chicago, IL 60637Make an Appointment
Hospital Highlight
Dr. Olopade is affiliated with The University of Chicago Medical Center Chicago, a highly rated hospital.
At a Glance
- Areas of ExpertiseDr. Olopade specializes in the areas of Internal Medicine & Medical Oncology. • See board certifications
- Practices at Top Hospital
- Hospital Satisfaction
- Low Wait TimesPatients are usually seen in 10 minutes or less.

Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Olopade's Reviews
Likelihood to recommend Dr. Olopade
1.0
5 Star | 0% | 0% |
4 Star | 0% | 0% |
3 Star | 0% | 0% |
2 Star | 0% | 0% |
1 Star | 100% | 100% |
Leave a review
How was your experience with Dr. Olopade?Overall Patient Satisfaction
Likelihood of recommending Dr. Olopade to family and friends is 1 out of 5
About Me
biography
Dr. Olufunmilayo Olopade, MD is a medical oncologist in Chicago, IL and has over 40 years of experience in the medical field. She graduated from University of Ibadan School of Medicine in 1980. She is affiliated with The University of Chicago Medical Center.Medical Oncology
Internal Medicine
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of Ibadan School Of Medicine
Medical School, 1980
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkA metabolome-wide case-control study of african american breast cancer patients, 2023-02-23
Translational Integrity and Continuity: Personalized Biomedical Data Integration, 2008-08-12
Two truncating variants inFANCCand breast cancer risk, 2019-08-29
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes, 2020-01-07
Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma, 2012-12-29
Population-dependent Intron Retention and DNA Methylation in Breast Cancer, 2018-01-12
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status, 2020-03-01
Clinical Significance of KISS1 Protein Expression for Brain Invasion and Metastasis, 2011-09-16
Novel germlinePALB2truncating mutations in African-American breast cancer patients, 2011-08-26
ß-catenin regulatesc-MycandCDKN1Aexpression in breast cancer cells, 2015-02-08
The use of allelic imbalance to ascertaincis-regulation for humanUGT2B7 in vivo, 2013-06-06
Proceedings from the 9thannual conference on the science of dissemination and implementation Washington, DC, USA. 14-15 December 2016, 2017-04-20
The molecular portraits of breast tumors are conserved across microarray platforms, 2006-04-27
Traditional medicine usage among adult women in Ibadan, Nigeria: a cross-sectional study, 2020-03-20
Tumor Genome Analysis Includes Germline Genome: Are We Ready for Surprises?, 2014-08-14
LncRNA BLAT1 is Upregulated in Basal-like Breast Cancer through Epigenetic Modifications, 2018-10-22
Longitudinal follow-up after telephone disclosure in the randomized COGENT Study, 2020-05-07
Performance of Lynch Syndrome Predictive Models in a Multi-center US Referral Population, 2011-07-12
GermlineHOXB13mutations p.G84E and p.R217C do not confer an increased breast cancer risk, 2020-06-16
Development of a Breast Cancer Risk Prediction Model for Women in Nigeria, 2018-04-20
Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer, 2016-11-02
Implementing oncology clinical trials in Nigeria: a model for capacity building, 2020-08-03
Differences in somaticTP53mutation type in breast tumors by race and receptor status, 2022-03-14
rs2981582 is associated withFGFR2expression in normal breast, 2009-12-03
The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions, 2023-02-18
Feasibility of genetic testing for cancer risk assessment programme in Nigeria, 2021-09-07
Ancestry-Shift Refinement Mapping of theC6orf97-ESR1Breast Cancer Susceptibility Locus, 2010-07-22
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer, 2016-07-07
A compact VEGF signature associated with distant metastases and poor outcomes, 2009-03-16
Subtype-specific expression ofMELKis partly due to copy number alterations in breast cancer, 2022-06-24
Shared heritability and functional enrichment across six solid cancers, 2019-01-25
Association analysis identifies 65 new breast cancer risk loci, 2017-10-23
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer, 2015-02-24
Racial differences in a high-risk colorectal cancer referral population: a single-center experience, 2011-03-10
Identification of six new susceptibility loci for invasive epithelial ovarian cancer, 2015-01-12
Genetic Variation inIGF2andHTRA1and Breast Cancer Risk amongBRCA1andBRCA2Carriers, 2011-06-27
Mutations in Context: Implications ofBRCATesting in Diverse Populations, 2018-05-18
The Breast-Thyroid Cancer Link: A Systematic Review and Meta-Analysis, 2015-11-30
No clinical utility ofKRASvariant rs61764370 for ovarian or breast cancer, 2015-05-02
A genome-wide association study of breast cancer in women of African ancestry, 2012-08-25
Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry, 2017-04-04
Modification ofBRCA1-Associated Breast and Ovarian Cancer Risk byBRCA1Interacting Genes, 2011-07-28
Benign breast disease and breast cancer risk in African women: A case-control study, 2023-09-01
A functionally significant SNP in TP53 and breast cancer risk in African-American women, 2017-02-27
Glucocorticoid receptor expression in breast cancer associates with older patient age, 2008-07-31
Oestrogen receptor status and survival in women with BRCA2-associated breast cancer, 2019-02-06
Focus on Breast Cancer
Locations
Practice
Practice
Affiliated Hospitals
- Recipient of 30
hospital awardsView all awardsAmerica's 250 Best Hospitals Award™ (2025, 2024, 2023)
Top 5% in the nation for consistently delivering clinical quality
View all patient feedbackHow patients felt about the care they received at this hospital.
86%Patients said they were given information about recovering at home2% higher than the national average
80%Patients said that doctors always listened to them and explained things well4% higher than the national average
Compare Providers
Providers shown based on Dr. Olopade's location and specialty. Show more Oncologists.
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.